These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35213541)

  • 1. The role of childrens' vaccination for COVID-19-Pareto-optimal allocations of vaccines.
    Gavish N; Katriel G
    PLoS Comput Biol; 2022 Feb; 18(2):e1009872. PubMed ID: 35213541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
    Han S; Cai J; Yang J; Zhang J; Wu Q; Zheng W; Shi H; Ajelli M; Zhou XH; Yu H
    Nat Commun; 2021 Aug; 12(1):4673. PubMed ID: 34344871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves.
    Bauer S; Contreras S; Dehning J; Linden M; Iftekhar E; Mohr SB; Olivera-Nappa A; Priesemann V
    PLoS Comput Biol; 2021 Sep; 17(9):e1009288. PubMed ID: 34473693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.
    Buhat CAH; Lutero DSM; Olave YH; Quindala KM; Recreo MGP; Talabis DASJ; Torres MC; Tubay JM; Rabajante JF
    Appl Health Econ Health Policy; 2021 Sep; 19(5):699-708. PubMed ID: 34169485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
    Min KD; Tak S
    Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model-based strategy for the COVID-19 vaccine roll-out in the Philippines.
    Escosio RAS; Cawiding OR; Hernandez BS; Mendoza RG; Mendoza VMP; Mohammad RZ; Pilar-Arceo CPC; Salonga PKN; Suarez FLE; Sy PW; Vergara THM; de Los Reyes AA
    J Theor Biol; 2023 Sep; 573():111596. PubMed ID: 37597691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions.
    Rao IJ; Brandeau ML
    Math Biosci; 2021 Jul; 337():108621. PubMed ID: 33915160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination hesitancy and challenges to mass vaccination.
    Chau CYC
    Hong Kong Med J; 2021 Oct; 27(5):377-379. PubMed ID: 34657836
    [No Abstract]   [Full Text] [Related]  

  • 12. Prioritizing COVID-19 vaccination. Part 2: Real-time comparison between single-dose and double-dose in Japan.
    Kobayashi T; Nishiura H
    Math Biosci Eng; 2022 May; 19(7):7410-7424. PubMed ID: 35730313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.
    Li M; Zu J; Zhang Y; Ma L; Shen M; Li Z; Ji F
    Virol J; 2022 Mar; 19(1):43. PubMed ID: 35292054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?
    Frenkel LD
    Allergy Asthma Proc; 2021 Sep; 42(5):378-385. PubMed ID: 34474707
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine given to children with comorbidities in England, December 2020-June 2021.
    Aiano F; Campbell C; Saliba V; Ramsay ME; Ladhani SN
    Arch Dis Child; 2022 Mar; 107(3):e16. PubMed ID: 34740880
    [No Abstract]   [Full Text] [Related]  

  • 17. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus of the Genetics Branch of the Chilean Society of Pediatrics on the prioritization of people with Down syndrome and rare diseases for vaccination against SARS-CoV-2].
    Faundes V; Pardo R; Cammarata-Scalisi F; Alarcon P; Lay-Son G; San Martin E
    Andes Pediatr; 2021 Apr; 92(2):309-315. PubMed ID: 34106172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal vaccination at high reproductive numbers: sharp transitions and counterintuitive allocations.
    Gavish N; Katriel G
    Proc Biol Sci; 2022 Sep; 289(1983):20221525. PubMed ID: 36168762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.